DermaDetect
AI-driven Digital Diagnostics for Skin Disorders
Company Overview
Snapshot
Founded in November 2016 by Eugene Dicker, Gennadi Schechtmann, Prof. Arieh Ingber, and Dr. Guy Steuer, DermaDetect operates with 1–10 employees. The company has raised a total of $4.35M across 6 funding rounds from 6 investors.
Business overview
DermaDetect develops AI-driven software for the remote diagnosis and treatment of skin disorders. Its platform integrates intelligent software to provide accessible, 24/7 skin diagnostics, serving dermatological disciplines. The company offers products like DermaDetect, DermaAssess, and DermaManage, which are based on its core technology. DermaDetect's FDA/CE-cleared platform is currently being rolled out across the Maccabi Health Services network in Israel, supporting over 2.5 million patients and augmenting clinical workflows for healthcare providers.
Strategic signal
DermaDetect's strategic rollout of its automated skin diagnosis application across the entire Maccabi Health Services network in Israel signals strong market validation and scalability for its AI-driven platform. This expansion demonstrates the company's ability to integrate its technology into large healthcare systems, empowering physicians and enhancing patient care for over 2.5 million individuals. For investors, this indicates a significant step towards broader adoption and potential for increased revenue streams within the digital health and medical diagnostics sector.
Log in to access full profile ›Company Intelligence Q&A
- When was DermaDetect founded and by whom?
- DermaDetect was founded in November 2016 by Eugene Dicker, Gennadi Schechtmann, Prof. Arieh Ingber, and Dr. Guy Steuer.
- What is DermaDetect's primary product offering?
- DermaDetect offers an AI-driven software platform for the remote diagnosis and treatment of skin disorders, including products like DermaDetect, DermaAssess, and DermaManage.
- Which organization is implementing DermaDetect's technology in Israel?
- DermaDetect is rolling out its automated skin diagnosis application across the entire Maccabi Health Services network in Israel.
- Has DermaDetect received any grants?
- In December 2022, DermaDetect received a grant of $285,700 from the Israel Innovation Authority.